Literature DB >> 15727269

Extracellular proteolytic pathophysiology in the neurovascular unit after stroke.

Sun-Ryung Lee1, Xiaoying Wang, Kiyoshi Tsuji, Eng H Lo.   

Abstract

The NINDS Stroke Progress Review Group recommended a shift in emphasis from a purely neurocentric view of cell death towards a more integrative approach whereby responses in all brain cells and matrix are considered. The neurovascular unit (fundamentally comprising endothelium, astrocyte, and neuron) provides a conceptual framework where cell-cell and cell-matrix signaling underlies the overall tissue response to stroke and its treatments. Here, we briefly review recent data on extracellular proteolytic dysfunction in the neurovascular unit after a stroke. The breakdown of neurovascular matrix initiates blood-brain barrier disruption with edema and/or hemorrhage. Endothelial dysfunction amplifies inflammatory responses. Perturbation of cell-matrix homeostasis triggers multiple cell death pathways. Interactions between the major classes of extracellular proteases from the plasminogen and matrix metalloprotease families may underlie processes responsible for some of the hemorrhagic complications of thrombolytic stroke therapy. Targeting the proteolytic imbalance within the neurovascular unit may provide new approaches for improving the safety and efficacy of thrombolytic reperfusion therapy for stroke.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15727269     DOI: 10.1179/016164104X3806

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  15 in total

Review 1.  Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers.

Authors:  Wei Wang; Mingchang Li; Qianxue Chen; Jian Wang
Journal:  Mol Neurobiol       Date:  2014-11-04       Impact factor: 5.590

2.  Astrocytes and pericytes differentially modulate blood-brain barrier characteristics during development and hypoxic insult.

Authors:  Abraham Al Ahmad; Carole Bürgi Taboada; Max Gassmann; Omolara O Ogunshola
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-08       Impact factor: 6.200

Review 3.  The High Cost of Stroke and Stroke Cytoprotection Research.

Authors:  Paul A Lapchak; John H Zhang
Journal:  Transl Stroke Res       Date:  2016-12-30       Impact factor: 6.829

4.  Neuroprotection and vasculoprotection using genetically targeted protease-ligands.

Authors:  Padmesh S Rajput; Jessica A Lamb; Jose Á Fernández; Jilin Bai; Benedict R Pereira; I-Farn Lei; Jennifer Leung; John H Griffin; Patrick D Lyden
Journal:  Brain Res       Date:  2019-03-14       Impact factor: 3.252

5.  Cytokine regulation of MMP-9 in peripheral glia: implications for pathological processes and pain in injured nerve.

Authors:  Sharmila Chattopadhyay; Robert R Myers; Julie Janes; Veronica Shubayev
Journal:  Brain Behav Immun       Date:  2006-12-26       Impact factor: 7.217

6.  Intracerebroventricular Delivery of Recombinant NAMPT Deters Inflammation and Protects Against Cerebral Ischemia.

Authors:  Fenghua Chen; Zhongfang Weng; Qinghai Xia; Catherine Cao; Rehana K Leak; Lihong Han; Jian Xiao; Steven H Graham; Guodong Cao
Journal:  Transl Stroke Res       Date:  2019-02-28       Impact factor: 6.829

7.  Regulation of Dipeptidyl Peptidase IV in the Post-stroke Rat Brain and In Vitro Ischemia: Implications for Chemokine-Mediated Neural Progenitor Cell Migration and Angiogenesis.

Authors:  Umadevi V Wesley; James F Hatcher; Emine R Ayvaci; Abby Klemp; Robert J Dempsey
Journal:  Mol Neurobiol       Date:  2016-08-15       Impact factor: 5.590

Review 8.  Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery.

Authors:  R R Moustafa; J-C Baron
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

9.  Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice.

Authors:  Peter H Larsen; Angelika Goncalves DaSilva; Katherine Conant; V Wee Yong
Journal:  J Neurosci       Date:  2006-02-22       Impact factor: 6.167

10.  Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke.

Authors:  Haihao Zhu; Xiang Fan; Zhanyang Yu; Jianxiang Liu; Yoshihiro Murata; Jie Lu; Song Zhao; Katherine A Hajjar; Eng H Lo; Xiaoying Wang
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-13       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.